Birnur Ozbas-Erdem is a principal in the Life Sciences Practice of CRA. She has more than 10 years of experience with US and Global data analytics and modeling, with over four years of experience in the pharmaceutical industry. Dr. Ozbas-Erdem’s expertise is within advanced data analysis, market sizing and segmentation, patient flow and journey, and source of business. She focuses complex disease areas including neuroscience and immunology. Dr. Ozbas-Erdem’s project work includes strategy development, market research, discrete event simulation, system dynamics, mathematical modeling, and risk analysis. Prior to CRA’s acquisition of C1 Consulting in 2017, Dr. Ozbas-Erdem was a manager at C1 Consulting.